Marvel Biosciences Corp (MRVL) — Net Asset Momentum
Marvel Biosciences Corp (MRVL) recorded a net asset momentum of -41.8% as of July 2025, with net assets of CA$-4.01 Million CAD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Marvel Biosciences Corp (MRVL) liquidity interval to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Marvel Biosciences Corp Net Asset Momentum (2020–2025)
This chart tracks Marvel Biosciences Corp's year-over-year net asset growth across 6 annual reporting periods from 2020 to 2025. The most recent momentum reading is -41.8%, with net assets of CA$-4.01 Million CAD as of July 2025. Read MRVL total debt and obligations for a breakdown of total debt and financial obligations.
Annual Net Asset History for Marvel Biosciences Corp (2020–2025)
The table below shows the complete annual net asset history for Marvel Biosciences Corp from 2020 to 2025, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see how much is Marvel Biosciences Corp worth.
| Year | Net Assets (CAD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CA$-4.01 Million | CA$326.71K | CA$4.33 Million | ▼ -41.8% |
| 2024 | CA$-2.83 Million | CA$491.31K | CA$3.32 Million | ▼ -64.3% |
| 2023 | CA$-1.72 Million | CA$672.39K | CA$2.39 Million | ▼ -979.7% |
| 2022 | CA$195.54K | CA$913.54K | CA$718.00K | ▼ -91.7% |
| 2021 | CA$2.36 Million | CA$2.47 Million | CA$112.48K | ▲ +1882.8% |
| 2020 | CA$118.80K | CA$295.99K | CA$177.18K | — |